511 related articles for article (PubMed ID: 36426395)
1. Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update.
Wang C; Bao Y; Chen J; Chen X; Cheng L; Guo YS; Hao C; Lai H; Li H; Li J; Liu C; Liu Y; Liu Z; Lou H; Lv W; Nong G; Qiu Q; Ren X; Shao J; Shen YH; Shi L; Song XC; Song Y; Tang S; Wang H; Wang X; Wang X; Wang Z; Wei Q; Xie H; Xing Z; Xu R; Xu Y; Yang Q; Yao H; Ye J; You Y; Yu H; Yu Y; Zhang H; Zhang G; Zhang Y; Zhi Y; Zhou W; Zhu L; Zhu X; Chai R; Chen D; Guan K; Huang Z; Huang Y; Ma T; Ma Y; Meng Y; Ren L; Wang J; Wang N; Xian M; Xiang R; Zheng M; Zhang L;
Allergy Asthma Immunol Res; 2022 Nov; 14(6):604-652. PubMed ID: 36426395
[TBL] [Abstract][Full Text] [Related]
2. Chinese Guideline on allergen immunotherapy for allergic rhinitis.
Bao Y; Chen J; Cheng L; Guo Y; Hong S; Kong W; Lai H; Li H; Li H; Li J; Li T; Lin X; Liu S; Liu Z; Lou H; Meng J; Qiu Q; Shen K; Tang W; Tao Z; Wang C; Wang X; Wei Q; Xiang L; Xie H; Xu Y; Zhang G; Zhang Y; Zheng Y; Zhi Y; Chen D; Hong H; Li Q; Liu L; Meng Y; Wang N; Wang Y; Zhou Y; Zhang L;
J Thorac Dis; 2017 Nov; 9(11):4607-4650. PubMed ID: 29268533
[TBL] [Abstract][Full Text] [Related]
3. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
Front Immunol; 2021; 12():786738. PubMed ID: 35197963
[TBL] [Abstract][Full Text] [Related]
4. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis.
Feng M; Zeng X; Li J
J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069
[TBL] [Abstract][Full Text] [Related]
5. Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis.
Yao Y; Wang ZC; Wang N; Zhou PC; Chen CL; Song J; Pan L; Liao B; Zhang XH; Yang YS; Xu XY; Zhu RF; Yu D; Liu Z
J Allergy Clin Immunol; 2019 Jul; 144(1):118-128. PubMed ID: 30796979
[TBL] [Abstract][Full Text] [Related]
6. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in the Treatment of Allergic Rhinitis in Children.
Alamri RA; Aljabri GH; Tahlawi R; Aljabri HA
Cureus; 2022 Dec; 14(12):e32464. PubMed ID: 36644088
[TBL] [Abstract][Full Text] [Related]
8. Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
Feng M; Luo T; Xian M; Shi X; Qin R; Zeng X; Su Q; Li J
Clin Exp Allergy; 2022 Jul; 52(7):878-887. PubMed ID: 34962673
[TBL] [Abstract][Full Text] [Related]
9. Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
Boonpiyathad T; Lao-Araya M; Chiewchalermsri C; Sangkanjanavanich S; Morita H
Front Allergy; 2021; 2():747323. PubMed ID: 35387059
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of immunotherapy response in patients with allergic rhinitis.
Licari A; Castagnoli R; Brambilla I; Tosca MA; De Filippo M; Marseglia G; Ciprandi G
Expert Rev Clin Immunol; 2018 Aug; 14(8):657-663. PubMed ID: 30039714
[TBL] [Abstract][Full Text] [Related]
11. EAACI guidelines on allergen immunotherapy: Prevention of allergy.
Halken S; Larenas-Linnemann D; Roberts G; Calderón MA; Angier E; Pfaar O; Ryan D; Agache I; Ansotegui IJ; Arasi S; Du Toit G; Fernandez-Rivas M; Geerth van Wijk R; Jutel M; Kleine-Tebbe J; Lau S; Matricardi PM; Pajno GB; Papadopoulos NG; Penagos M; Santos AF; Sturm GJ; Timmermans F; van Ree R; Varga EM; Wahn U; Kristiansen M; Dhami S; Sheikh A; Muraro A
Pediatr Allergy Immunol; 2017 Dec; 28(8):728-745. PubMed ID: 28902467
[TBL] [Abstract][Full Text] [Related]
12. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
[TBL] [Abstract][Full Text] [Related]
13. Allergen immunotherapy enhances the immunosuppressive effects of Treg cells to alleviate allergic rhinitis by decreasing PU-1+ Treg cell numbers.
Qiao YL; Jiao WE; Xu S; Kong YG; Deng YQ; Yang R; Hua QQ; Chen SM
Int Immunopharmacol; 2022 Nov; 112():109187. PubMed ID: 36037652
[TBL] [Abstract][Full Text] [Related]
14. Malaysian Society of Allergy and Immunology Consensus Statement on Sublingual Immunotherapy in Allergic Rhinitis.
Abdullah B; Pawankar R; Abdul Latiff AH; Woo KCK; Wüstenberg E; Khalid MAF; Xiang YZ; Husain S; Mohammad N; Md Shukri N
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769797
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of immune cell markers in allergic rhinitis for the evaluation of allergen immunotherapy].
Li H; Zhang Y; Tao Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):251-255;260. PubMed ID: 38433697
[No Abstract] [Full Text] [Related]
16. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial.
Bożek A; Kołodziejczyk K; Kozłowska R; Canonica GW
Clin Transl Allergy; 2017; 7():43. PubMed ID: 29214012
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mite allergen immunotherapy in allergic rhinitis and the immune synergistic effect on cross-allergens.
Zheng P; Liu X; Lin L; Wu H; Zhao X; Sun B
Immunotherapy; 2021 Nov; ():. PubMed ID: 34845913
[TBL] [Abstract][Full Text] [Related]
18. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice guideline: Allergic rhinitis.
Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
[TBL] [Abstract][Full Text] [Related]
20. Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients.
Huang Y; Wang C; Lin X; Lou H; Cao F; Li W; Zhang Y; Zhang L
Clin Transl Allergy; 2019; 9():64. PubMed ID: 31890153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
